1910 Genetics
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $26M
Investors
- 6
About 1910 Genetics
Based in Massachusetts, US, and established in 2018, 1910 Genetics operates as a biotechnology research organization. The biotech organization is founded by Jen Nwankwo (CEO). In September 2021, 1910 Genetics, Inc. 1910 Genetics first develops an understanding of the molecular basis of the disease, this works as the north star for the research and drives the integration of artificial intelligence computation and biological automation to accelerate the design of small molecule and protein therapeutics. The two discovery engines used by the organization are ELVIS™ and ROSALYND™. ELVIS™ includes SUEDE™ which is a screening technology, BAGEL™ which picks pharmacological features from the database and is input by experienced medical chemists, CANDID™ includes a graph neural network that excels at QSAR tasks and provides a platform for virtual screening and lead optimization. Similarly, ROSALYND™ also includes EMBARR™, AETHON™, and PEGASUS™. Its product is a multi-module drug discovery platform that uses machine learning to generate more novel drug candidates and help companies with their pharmaceutical research and development. As of 2022, the organization is applying its technology to drug discovery programs in neuroscience, infectious disease, immunology, and oncology.
Who invested in 1910 Genetics
6 investors across 2 rounds
See all investors in 1910 Genetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about 1910 Genetics
Who invested in 1910 Genetics?
1910 Genetics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 1910 Genetics raised?
1910 Genetics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did 1910 Genetics last raise money?
1910 Genetics's most recent round on record is a Series A, in Mar 2021.
What does 1910 Genetics do?
Based in Massachusetts, US, and established in 2018, 1910 Genetics operates as a biotechnology research organization.
Where is 1910 Genetics headquartered?
1910 Genetics is headquartered in Cambridge, US.
Which VCs invest in companies like 1910 Genetics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at 1910 Genetics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like 1910 Genetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.